Water Quality in ABERDEEN, NC (28315)
EPA violation data for public water systems serving ZIP code 28315.
754
Total Violations
74
Health-Based
680
Monitoring / Reporting
737
Resolved
What does this mean?
737 of 754 violations have been resolved. 74 are health-based violations, meaning contaminant levels exceeded federal safety limits. The remaining 680 are monitoring or reporting violations (missed testing deadlines or late paperwork — not necessarily a water quality issue). Not all violations mean your water is unsafe. The EPA requires reporting even for minor administrative issues.
Violations Detail (754 total)
| Contaminant | Category | MCL Limit | Measured | Date | Status | Health Effects |
|---|---|---|---|---|---|---|
| Combined Radium (-226 and -228) | Health-Based | N/A | 6 | Jun 30, 2025 | Resolved | N/A |
| Combined Radium (-226 and -228) | Health-Based | N/A | 6 | Jun 30, 2025 | Resolved | N/A |
| Combined Radium (-226 and -228) | Health-Based | N/A | 6 | Jun 30, 2025 | Resolved | N/A |
| Combined Radium (-226 and -228) | Health-Based | N/A | 7 | Mar 31, 2025 | Resolved | N/A |
| Combined Radium (-226 and -228) | Health-Based | N/A | 7 | Mar 31, 2025 | Resolved | N/A |
| Combined Radium (-226 and -228) | Health-Based | N/A | 7 | Mar 31, 2025 | Resolved | N/A |
| Combined Radium (-226 and -228) | Health-Based | N/A | 7 | Mar 31, 2025 | Resolved | N/A |
| Combined Radium (-226 and -228) | Health-Based | N/A | 6 | Dec 31, 2024 | Resolved | N/A |
| Combined Radium (-226 and -228) | Health-Based | N/A | 6 | Dec 31, 2024 | Resolved | N/A |
| Combined Radium (-226 and -228) | Health-Based | N/A | 6 | Dec 31, 2024 | Resolved | N/A |
| Total Haloacetic Acids (HAA5) | Monitoring | N/A | N/A | Dec 31, 2024 | Active | N/A |
| Combined Radium (-226 and -228) | Health-Based | N/A | 6 | Dec 31, 2024 | Resolved | N/A |
| TTHM | Monitoring | N/A | N/A | Dec 31, 2024 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Dec 26, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Dec 26, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Dec 26, 2024 | Resolved | N/A |
| Chlorine | Monitoring | N/A | N/A | Oct 31, 2024 | Resolved | Eye and nose irritation; stomach discomfort |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Oct 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Oct 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Oct 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Oct 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Oct 31, 2024 | Resolved | N/A |
| Chlorine | Monitoring | N/A | N/A | Oct 31, 2024 | Resolved | Eye and nose irritation; stomach discomfort |
| Chlorine | Monitoring | N/A | N/A | Oct 31, 2024 | Resolved | Eye and nose irritation; stomach discomfort |
| Chlorine | Monitoring | N/A | N/A | Oct 31, 2024 | Resolved | Eye and nose irritation; stomach discomfort |
| Chlorine | Monitoring | N/A | N/A | Oct 31, 2024 | Resolved | Eye and nose irritation; stomach discomfort |
| Nitrate | Monitoring | N/A | N/A | Sep 30, 2024 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Sep 30, 2024 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Sep 30, 2024 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Sep 30, 2024 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Sep 30, 2024 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Combined Radium (-226 and -228) | Health-Based | N/A | 6 | Sep 30, 2024 | Resolved | N/A |
| Combined Radium (-226 and -228) | Health-Based | N/A | 6 | Sep 30, 2024 | Resolved | N/A |
| Combined Radium (-226 and -228) | Health-Based | N/A | 6 | Sep 30, 2024 | Resolved | N/A |
| Combined Radium (-226 and -228) | Health-Based | N/A | 6 | Sep 30, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2024 | Resolved | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | May 26, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 10, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 10, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 10, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 10, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 10, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 12, 2024 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Mar 31, 2024 | Active | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Mar 31, 2024 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Mar 8, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Mar 8, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Mar 8, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 22, 2024 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 22, 2024 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 8, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 8, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 8, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jan 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jan 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jan 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jan 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jan 31, 2024 | Resolved | N/A |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Chlorine | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Eye and nose irritation; stomach discomfort |
| Combined Radium (-226 and -228) | Health-Based | N/A | 6 | Dec 31, 2023 | Resolved | N/A |
| Combined Radium (-226 and -228) | Health-Based | N/A | 6 | Dec 31, 2023 | Resolved | N/A |
| Combined Radium (-226 and -228) | Health-Based | N/A | 6 | Dec 31, 2023 | Resolved | N/A |
| Combined Radium (-226 and -228) | Health-Based | N/A | 6 | Dec 31, 2023 | Resolved | N/A |
| Combined Radium (-226 and -228) | Health-Based | N/A | 6 | Dec 31, 2023 | Resolved | N/A |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Chlorine | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Eye and nose irritation; stomach discomfort |
| Chlorine | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Eye and nose irritation; stomach discomfort |
| Chlorine | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Eye and nose irritation; stomach discomfort |
| Chlorine | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Eye and nose irritation; stomach discomfort |
| Chlorine | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Eye and nose irritation; stomach discomfort |
| Chlorine | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Eye and nose irritation; stomach discomfort |
| Chlorine | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Eye and nose irritation; stomach discomfort |
| Chlorine | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Eye and nose irritation; stomach discomfort |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Dec 16, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Dec 16, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Dec 16, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Dec 15, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Dec 15, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Dec 15, 2023 | Resolved | N/A |
| E. COLI | Monitoring | 0 | N/A | Dec 4, 2023 | Active | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Dec 4, 2023 | Active | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Dec 4, 2023 | Active | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Dec 4, 2023 | Active | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| Public Notice | Monitoring | N/A | N/A | Nov 10, 2023 | Resolved | N/A |
| E. COLI | Monitoring | 0 | N/A | Nov 4, 2023 | Active | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Nov 4, 2023 | Active | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Nov 4, 2023 | Active | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Nov 4, 2023 | Active | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Oct 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Oct 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Oct 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Oct 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Oct 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Oct 31, 2023 | Resolved | N/A |
| Radium-228 | Monitoring | N/A | N/A | Sep 30, 2023 | Resolved | Increased risk of cancer |
| Radium-226 | Monitoring | N/A | N/A | Sep 30, 2023 | Resolved | Increased risk of cancer |
| Radium-226 | Monitoring | N/A | N/A | Sep 30, 2023 | Resolved | Increased risk of cancer |
| Radium-226 | Monitoring | N/A | N/A | Sep 30, 2023 | Resolved | Increased risk of cancer |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2023 | Resolved | N/A |
| Combined Radium (-226 and -228) | Health-Based | N/A | 7 | Sep 30, 2023 | Resolved | N/A |
| Combined Radium (-226 and -228) | Health-Based | N/A | 7 | Sep 30, 2023 | Resolved | N/A |
| Combined Radium (-226 and -228) | Health-Based | N/A | 7 | Sep 30, 2023 | Resolved | N/A |
| Combined Radium (-226 and -228) | Health-Based | N/A | 7 | Sep 30, 2023 | Resolved | N/A |
| Combined Radium (-226 and -228) | Health-Based | N/A | 7 | Sep 30, 2023 | Resolved | N/A |
| Chlorine | Monitoring | N/A | N/A | Sep 30, 2023 | Resolved | Eye and nose irritation; stomach discomfort |
| Radium-228 | Monitoring | N/A | N/A | Sep 30, 2023 | Resolved | Increased risk of cancer |
| Combined Radium (-226 and -228) | Monitoring | N/A | N/A | Sep 30, 2023 | Resolved | N/A |
| Combined Radium (-226 and -228) | Monitoring | N/A | N/A | Sep 30, 2023 | Resolved | N/A |
| Combined Radium (-226 and -228) | Monitoring | N/A | N/A | Sep 30, 2023 | Resolved | N/A |
| Combined Radium (-226 and -228) | Monitoring | N/A | N/A | Sep 30, 2023 | Resolved | N/A |
| Combined Radium (-226 and -228) | Monitoring | N/A | N/A | Sep 30, 2023 | Resolved | N/A |
| Chlorine | Monitoring | N/A | N/A | Sep 30, 2023 | Resolved | Eye and nose irritation; stomach discomfort |
| Chlorine | Monitoring | N/A | N/A | Sep 30, 2023 | Resolved | Eye and nose irritation; stomach discomfort |
| Chlorine | Monitoring | N/A | N/A | Sep 30, 2023 | Resolved | Eye and nose irritation; stomach discomfort |
| Chlorine | Monitoring | N/A | N/A | Sep 30, 2023 | Resolved | Eye and nose irritation; stomach discomfort |
| Combined Uranium | Monitoring | N/A | N/A | Sep 30, 2023 | Resolved | N/A |
| Radium-226 | Monitoring | N/A | N/A | Sep 30, 2023 | Resolved | Increased risk of cancer |
| Radium-226 | Monitoring | N/A | N/A | Sep 30, 2023 | Resolved | Increased risk of cancer |
| Combined Uranium | Monitoring | N/A | N/A | Sep 30, 2023 | Resolved | N/A |
| Combined Uranium | Monitoring | N/A | N/A | Sep 30, 2023 | Resolved | N/A |
| Combined Uranium | Monitoring | N/A | N/A | Sep 30, 2023 | Resolved | N/A |
| Combined Uranium | Monitoring | N/A | N/A | Sep 30, 2023 | Resolved | N/A |
| Radium-228 | Monitoring | N/A | N/A | Sep 30, 2023 | Resolved | Increased risk of cancer |
| Radium-228 | Monitoring | N/A | N/A | Sep 30, 2023 | Resolved | Increased risk of cancer |
| Radium-228 | Monitoring | N/A | N/A | Sep 30, 2023 | Resolved | Increased risk of cancer |
| Gross Alpha, Excl. Radon and U | Monitoring | N/A | N/A | Sep 30, 2023 | Resolved | N/A |
| Gross Alpha, Excl. Radon and U | Monitoring | N/A | N/A | Sep 30, 2023 | Resolved | N/A |
| Gross Alpha, Excl. Radon and U | Monitoring | N/A | N/A | Sep 30, 2023 | Resolved | N/A |
| Gross Alpha, Excl. Radon and U | Monitoring | N/A | N/A | Sep 30, 2023 | Resolved | N/A |
| Gross Alpha, Excl. Radon and U | Monitoring | N/A | N/A | Sep 30, 2023 | Resolved | N/A |
| Gross Alpha, Excl. Radon and U | Monitoring | N/A | N/A | Sep 30, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Aug 6, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Aug 6, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Aug 6, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jul 12, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jul 12, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jul 12, 2023 | Resolved | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2023 | Active | N/A |
| Combined Uranium | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | N/A |
| Gross Alpha, Excl. Radon and U | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | N/A |
| Gross Alpha, Excl. Radon and U | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | N/A |
| Gross Alpha, Excl. Radon and U | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | N/A |
| Gross Alpha, Excl. Radon and U | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | N/A |
| Combined Uranium | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | N/A |
| Combined Uranium | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | N/A |
| Combined Uranium | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | N/A |
| Combined Uranium | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | N/A |
| Radium-226 | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | Increased risk of cancer |
| Radium-226 | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | Increased risk of cancer |
| Radium-226 | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | Increased risk of cancer |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | N/A |
| Combined Radium (-226 and -228) | Health-Based | N/A | 7 | Jun 30, 2023 | Resolved | N/A |
| Combined Radium (-226 and -228) | Health-Based | N/A | 7 | Jun 30, 2023 | Resolved | N/A |
| Combined Radium (-226 and -228) | Health-Based | N/A | 7 | Jun 30, 2023 | Resolved | N/A |
| Radium-226 | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | Increased risk of cancer |
| Radium-226 | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | Increased risk of cancer |
| Chlorine | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | Eye and nose irritation; stomach discomfort |
| Chlorine | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | Eye and nose irritation; stomach discomfort |
| Chlorine | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | Eye and nose irritation; stomach discomfort |
| Lead and Copper Rule | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | N/A |
| Chlorine | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | Eye and nose irritation; stomach discomfort |
| Chlorine | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | Eye and nose irritation; stomach discomfort |
| Combined Radium (-226 and -228) | Health-Based | N/A | 7 | Jun 30, 2023 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | N/A |
| Combined Radium (-226 and -228) | Health-Based | N/A | 7 | Jun 30, 2023 | Resolved | N/A |
| Radium-228 | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | Increased risk of cancer |
| Radium-228 | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | Increased risk of cancer |
| Nitrate | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | N/A |
| Gross Alpha, Excl. Radon and U | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2023 | Active | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2023 | Active | N/A |
| Combined Radium (-226 and -228) | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | N/A |
| Combined Radium (-226 and -228) | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | N/A |
| Combined Radium (-226 and -228) | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | N/A |
| Combined Radium (-226 and -228) | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | N/A |
| Combined Radium (-226 and -228) | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | N/A |
| Radium-228 | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | Increased risk of cancer |
| Radium-228 | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | Increased risk of cancer |
| Radium-228 | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | Increased risk of cancer |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2023 | Resolved | N/A |
| Radium-226 | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | Increased risk of cancer |
| Radium-226 | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | Increased risk of cancer |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | N/A |
| Nitrate | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Gross Alpha, Excl. Radon and U | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | N/A |
| Gross Alpha, Excl. Radon and U | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | N/A |
| Gross Alpha, Excl. Radon and U | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | N/A |
| Radium-226 | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | Increased risk of cancer |
| Gross Alpha, Excl. Radon and U | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | N/A |
| Gross Alpha, Excl. Radon and U | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | N/A |
| Gross Alpha, Excl. Radon and U | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | N/A |
| Combined Uranium | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | N/A |
| Combined Uranium | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | N/A |
| Combined Uranium | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | N/A |
| Combined Radium (-226 and -228) | Health-Based | N/A | 7 | Mar 31, 2023 | Resolved | N/A |
| Combined Radium (-226 and -228) | Health-Based | N/A | 7 | Mar 31, 2023 | Resolved | N/A |
| Combined Uranium | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | N/A |
| Combined Uranium | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | N/A |
| Chlorine | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | Eye and nose irritation; stomach discomfort |
| Chlorine | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | Eye and nose irritation; stomach discomfort |
| Radium-226 | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | Increased risk of cancer |
| Combined Radium (-226 and -228) | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | N/A |
| Combined Radium (-226 and -228) | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | N/A |
| Combined Radium (-226 and -228) | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | N/A |
| Combined Radium (-226 and -228) | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | N/A |
| Combined Radium (-226 and -228) | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | N/A |
| Radium-228 | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | Increased risk of cancer |
| Radium-228 | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | Increased risk of cancer |
| Radium-228 | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | Increased risk of cancer |
| Radium-228 | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | Increased risk of cancer |
| Radium-228 | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | Increased risk of cancer |
| Combined Radium (-226 and -228) | Health-Based | N/A | 7 | Mar 31, 2023 | Resolved | N/A |
| Combined Radium (-226 and -228) | Health-Based | N/A | 7 | Mar 31, 2023 | Resolved | N/A |
| Combined Radium (-226 and -228) | Health-Based | N/A | 7 | Mar 31, 2023 | Resolved | N/A |
| Nitrate | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Chlorine | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | Eye and nose irritation; stomach discomfort |
| Chlorine | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | Eye and nose irritation; stomach discomfort |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | N/A |
| Radium-226 | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | Increased risk of cancer |
| Chlorine | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | Eye and nose irritation; stomach discomfort |
| Nitrate | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 28, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 28, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 28, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 28, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 28, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 19, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 19, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 19, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jan 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jan 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jan 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jan 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jan 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jan 31, 2023 | Resolved | N/A |
| Radium-226 | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Increased risk of cancer |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Radium-226 | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Increased risk of cancer |
| Radium-226 | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Increased risk of cancer |
| Radium-226 | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Increased risk of cancer |
| Radium-226 | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Increased risk of cancer |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Radium-228 | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Increased risk of cancer |
| Radium-228 | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Increased risk of cancer |
| Radium-228 | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Increased risk of cancer |
| Radium-228 | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Increased risk of cancer |
| Radium-228 | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Increased risk of cancer |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Combined Radium (-226 and -228) | Health-Based | N/A | 7 | Dec 31, 2022 | Resolved | N/A |
| Gross Alpha, Excl. Radon and U | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Gross Alpha, Excl. Radon and U | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Gross Alpha, Excl. Radon and U | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Gross Alpha, Excl. Radon and U | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Gross Alpha, Excl. Radon and U | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Combined Uranium | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Combined Radium (-226 and -228) | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Combined Radium (-226 and -228) | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Combined Radium (-226 and -228) | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Combined Radium (-226 and -228) | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Combined Radium (-226 and -228) | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Combined Uranium | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Combined Uranium | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Combined Uranium | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Combined Uranium | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Combined Radium (-226 and -228) | Health-Based | N/A | 7 | Dec 31, 2022 | Resolved | N/A |
| Combined Radium (-226 and -228) | Health-Based | N/A | 7 | Dec 31, 2022 | Resolved | N/A |
| Combined Radium (-226 and -228) | Health-Based | N/A | 7 | Dec 31, 2022 | Resolved | N/A |
| Combined Radium (-226 and -228) | Health-Based | N/A | 7 | Dec 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Nov 30, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Nov 30, 2022 | Resolved | N/A |
| Combined Radium (-226 and -228) | Health-Based | N/A | 7 | Sep 30, 2022 | Resolved | N/A |
| Combined Radium (-226 and -228) | Health-Based | N/A | 7 | Sep 30, 2022 | Resolved | N/A |
| Combined Radium (-226 and -228) | Health-Based | N/A | 7 | Sep 30, 2022 | Resolved | N/A |
| Combined Radium (-226 and -228) | Health-Based | N/A | 7 | Sep 30, 2022 | Resolved | N/A |
| Combined Radium (-226 and -228) | Health-Based | N/A | 7 | Sep 30, 2022 | Resolved | N/A |
| Chlorine | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | Eye and nose irritation; stomach discomfort |
| Chlorine | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | Eye and nose irritation; stomach discomfort |
| Chlorine | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | Eye and nose irritation; stomach discomfort |
| Chlorine | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | Eye and nose irritation; stomach discomfort |
| Chlorine | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | Eye and nose irritation; stomach discomfort |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2022 | Resolved | N/A |
| TTHM | Monitoring | N/A | N/A | Aug 31, 2022 | Resolved | N/A |
| TTHM | Monitoring | N/A | N/A | Aug 31, 2022 | Resolved | N/A |
| TTHM | Monitoring | N/A | N/A | Aug 31, 2022 | Resolved | N/A |
| TTHM | Monitoring | N/A | N/A | Aug 31, 2022 | Resolved | N/A |
| TTHM | Monitoring | N/A | N/A | Aug 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2022 | Resolved | N/A |
| TTHM | Monitoring | N/A | N/A | Aug 31, 2022 | Resolved | N/A |
| Total Haloacetic Acids (HAA5) | Monitoring | N/A | N/A | Aug 31, 2022 | Resolved | N/A |
| Total Haloacetic Acids (HAA5) | Monitoring | N/A | N/A | Aug 31, 2022 | Resolved | N/A |
| Total Haloacetic Acids (HAA5) | Monitoring | N/A | N/A | Aug 31, 2022 | Resolved | N/A |
| Total Haloacetic Acids (HAA5) | Monitoring | N/A | N/A | Aug 31, 2022 | Resolved | N/A |
| Total Haloacetic Acids (HAA5) | Monitoring | N/A | N/A | Aug 31, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Aug 26, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Aug 26, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Aug 26, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2022 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Radium-228 | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | Increased risk of cancer |
| Radium-228 | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | Increased risk of cancer |
| Radium-228 | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | Increased risk of cancer |
| Radium-228 | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | Increased risk of cancer |
| Radium-228 | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | Increased risk of cancer |
| Lead and Copper Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Combined Radium (-226 and -228) | Health-Based | N/A | 9 | Jun 30, 2022 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Gross Alpha, Excl. Radon and U | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Combined Radium (-226 and -228) | Health-Based | N/A | 9 | Jun 30, 2022 | Resolved | N/A |
| Combined Radium (-226 and -228) | Health-Based | N/A | 9 | Jun 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Gross Alpha, Excl. Radon and U | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Gross Alpha, Excl. Radon and U | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Gross Alpha, Excl. Radon and U | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Combined Uranium | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Combined Uranium | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Combined Uranium | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Chlorine | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | Eye and nose irritation; stomach discomfort |
| Chlorine | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | Eye and nose irritation; stomach discomfort |
| Gross Alpha, Excl. Radon and U | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Nitrate | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Gross Alpha, Excl. Radon and U | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Chlorine | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | Eye and nose irritation; stomach discomfort |
| Chlorine | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | Eye and nose irritation; stomach discomfort |
| Combined Uranium | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Combined Uranium | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Nitrate | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Combined Radium (-226 and -228) | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Combined Radium (-226 and -228) | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Combined Radium (-226 and -228) | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Combined Radium (-226 and -228) | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Combined Radium (-226 and -228) | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Radium-226 | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | Increased risk of cancer |
| Radium-226 | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | Increased risk of cancer |
| Radium-226 | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | Increased risk of cancer |
| Radium-226 | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | Increased risk of cancer |
| Radium-226 | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | Increased risk of cancer |
| Combined Radium (-226 and -228) | Health-Based | N/A | 9 | Jun 30, 2022 | Resolved | N/A |
| Combined Radium (-226 and -228) | Health-Based | N/A | 9 | Jun 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2022 | Resolved | N/A |
| Radium-226 | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | Increased risk of cancer |
| Nitrate | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Combined Uranium | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Combined Uranium | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Combined Uranium | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Combined Uranium | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Nitrate | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Radium-226 | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | Increased risk of cancer |
| Combined Radium (-226 and -228) | Health-Based | N/A | 9 | Mar 31, 2022 | Resolved | N/A |
| Combined Radium (-226 and -228) | Health-Based | N/A | 9 | Mar 31, 2022 | Resolved | N/A |
| Combined Radium (-226 and -228) | Health-Based | N/A | 9 | Mar 31, 2022 | Resolved | N/A |
| Combined Radium (-226 and -228) | Health-Based | N/A | 9 | Mar 31, 2022 | Resolved | N/A |
| Radium-226 | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | Increased risk of cancer |
| Radium-226 | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | Increased risk of cancer |
| Radium-226 | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | Increased risk of cancer |
| Combined Radium (-226 and -228) | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Nitrate | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Combined Radium (-226 and -228) | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Combined Radium (-226 and -228) | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Combined Radium (-226 and -228) | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Combined Radium (-226 and -228) | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Gross Alpha, Excl. Radon and U | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Gross Alpha, Excl. Radon and U | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Gross Alpha, Excl. Radon and U | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Gross Alpha, Excl. Radon and U | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Gross Alpha, Excl. Radon and U | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Gross Alpha, Excl. Radon and U | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Combined Uranium | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Combined Radium (-226 and -228) | Health-Based | N/A | 9 | Mar 31, 2022 | Resolved | N/A |
| Nitrate | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Radium-228 | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | Increased risk of cancer |
| Radium-228 | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | Increased risk of cancer |
| Radium-228 | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | Increased risk of cancer |
| Radium-228 | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | Increased risk of cancer |
| Radium-228 | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | Increased risk of cancer |
| Chlorine | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | Eye and nose irritation; stomach discomfort |
| Chlorine | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | Eye and nose irritation; stomach discomfort |
| Chlorine | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | Eye and nose irritation; stomach discomfort |
| Chlorine | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | Eye and nose irritation; stomach discomfort |
| Chlorine | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | Eye and nose irritation; stomach discomfort |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 28, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 28, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 28, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 28, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 28, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 28, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 9, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jan 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jan 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jan 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jan 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jan 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jan 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Combined Uranium | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Combined Uranium | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Combined Uranium | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Combined Uranium | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Combined Uranium | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Combined Radium (-226 and -228) | Health-Based | N/A | 9 | Dec 31, 2021 | Resolved | N/A |
| Combined Radium (-226 and -228) | Health-Based | N/A | 9 | Dec 31, 2021 | Resolved | N/A |
| Gross Alpha, Excl. Radon and U | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Gross Alpha, Excl. Radon and U | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Gross Alpha, Excl. Radon and U | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Gross Alpha, Excl. Radon and U | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Gross Alpha, Excl. Radon and U | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Combined Radium (-226 and -228) | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Combined Radium (-226 and -228) | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Combined Radium (-226 and -228) | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Combined Radium (-226 and -228) | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Combined Radium (-226 and -228) | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Radium-226 | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Increased risk of cancer |
| Radium-226 | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Increased risk of cancer |
| Radium-226 | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Increased risk of cancer |
| Radium-226 | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Increased risk of cancer |
| Radium-226 | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Increased risk of cancer |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Combined Radium (-226 and -228) | Health-Based | N/A | 9 | Dec 31, 2021 | Resolved | N/A |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Radium-228 | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Increased risk of cancer |
| Radium-228 | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Increased risk of cancer |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Chlorine | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Eye and nose irritation; stomach discomfort |
| Chlorine | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Eye and nose irritation; stomach discomfort |
| Chlorine | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Eye and nose irritation; stomach discomfort |
| Radium-228 | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Increased risk of cancer |
| Radium-228 | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Increased risk of cancer |
| Radium-228 | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Increased risk of cancer |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Combined Radium (-226 and -228) | Health-Based | N/A | 9 | Dec 31, 2021 | Resolved | N/A |
| Gross Alpha, Excl. Radon and U | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Chlorine | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Eye and nose irritation; stomach discomfort |
| Chlorine | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Eye and nose irritation; stomach discomfort |
| Radium-228 | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | Increased risk of cancer |
| Radium-228 | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | Increased risk of cancer |
| Radium-228 | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | Increased risk of cancer |
| Combined Uranium | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Combined Uranium | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Combined Uranium | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Combined Uranium | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Combined Uranium | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Nitrate | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Combined Radium (-226 and -228) | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Combined Radium (-226 and -228) | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Combined Radium (-226 and -228) | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Combined Radium (-226 and -228) | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Gross Alpha, Excl. Radon and U | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Radium-228 | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | Increased risk of cancer |
| Radium-228 | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | Increased risk of cancer |
| Radium-226 | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | Increased risk of cancer |
| Radium-226 | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | Increased risk of cancer |
| Combined Radium (-226 and -228) | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Radium-226 | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | Increased risk of cancer |
| Radium-226 | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | Increased risk of cancer |
| Radium-226 | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | Increased risk of cancer |
| Gross Alpha, Excl. Radon and U | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Gross Alpha, Excl. Radon and U | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Nitrate | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Gross Alpha, Excl. Radon and U | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Gross Alpha, Excl. Radon and U | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Combined Radium (-226 and -228) | Health-Based | N/A | 9 | Sep 30, 2021 | Resolved | N/A |
| Combined Radium (-226 and -228) | Health-Based | N/A | 9 | Sep 30, 2021 | Resolved | N/A |
| Combined Radium (-226 and -228) | Health-Based | N/A | 9 | Sep 30, 2021 | Resolved | N/A |
| Combined Radium (-226 and -228) | Health-Based | N/A | 9 | Sep 30, 2021 | Resolved | N/A |
| Combined Radium (-226 and -228) | Health-Based | N/A | 9 | Sep 30, 2021 | Resolved | N/A |
| Combined Radium (-226 and -228) | Health-Based | N/A | 9 | Sep 30, 2021 | Resolved | N/A |
| Combined Radium (-226 and -228) | Health-Based | N/A | 9 | Sep 30, 2021 | Resolved | N/A |
| Gross Alpha, Excl. Radon and U | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2021 | Resolved | N/A |
| TTHM | Monitoring | N/A | N/A | Aug 31, 2021 | Resolved | N/A |
| TTHM | Monitoring | N/A | N/A | Aug 31, 2021 | Resolved | N/A |
| TTHM | Monitoring | N/A | N/A | Aug 31, 2021 | Resolved | N/A |
| TTHM | Monitoring | N/A | N/A | Aug 31, 2021 | Resolved | N/A |
| TTHM | Monitoring | N/A | N/A | Aug 31, 2021 | Resolved | N/A |
| TTHM | Monitoring | N/A | N/A | Aug 31, 2021 | Resolved | N/A |
| Total Haloacetic Acids (HAA5) | Monitoring | N/A | N/A | Aug 31, 2021 | Resolved | N/A |
| Total Haloacetic Acids (HAA5) | Monitoring | N/A | N/A | Aug 31, 2021 | Resolved | N/A |
| Total Haloacetic Acids (HAA5) | Monitoring | N/A | N/A | Aug 31, 2021 | Resolved | N/A |
| Total Haloacetic Acids (HAA5) | Monitoring | N/A | N/A | Aug 31, 2021 | Resolved | N/A |
| Total Haloacetic Acids (HAA5) | Monitoring | N/A | N/A | Aug 31, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Aug 28, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Aug 28, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Aug 28, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Aug 28, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Aug 13, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Aug 7, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2021 | Resolved | N/A |
| Nitrate | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Radium-226 | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | Increased risk of cancer |
| Radium-226 | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | Increased risk of cancer |
| Radium-226 | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | Increased risk of cancer |
| Radium-226 | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | Increased risk of cancer |
| Lead and Copper Rule | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |
| Combined Radium (-226 and -228) | Health-Based | N/A | 9 | Jun 30, 2021 | Resolved | N/A |
| Combined Radium (-226 and -228) | Health-Based | N/A | 9 | Jun 30, 2021 | Resolved | N/A |
| Combined Radium (-226 and -228) | Health-Based | N/A | 9 | Jun 30, 2021 | Resolved | N/A |
| Combined Radium (-226 and -228) | Health-Based | N/A | 9 | Jun 30, 2021 | Resolved | N/A |
| Nitrate | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |
| Gross Alpha, Excl. Radon and U | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |
| Gross Alpha, Excl. Radon and U | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |
| Gross Alpha, Excl. Radon and U | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |
| Gross Alpha, Excl. Radon and U | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |
| Combined Uranium | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |
| Combined Uranium | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |
| Combined Uranium | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |
| Combined Uranium | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |
| Combined Radium (-226 and -228) | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |
| Combined Radium (-226 and -228) | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |
| Combined Radium (-226 and -228) | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |
| Combined Radium (-226 and -228) | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |
| Chlorine | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | Eye and nose irritation; stomach discomfort |
| Chlorine | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | Eye and nose irritation; stomach discomfort |
| Chlorine | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | Eye and nose irritation; stomach discomfort |
| Chlorine | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | Eye and nose irritation; stomach discomfort |
| Chlorine | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | Eye and nose irritation; stomach discomfort |
| Radium-228 | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | Increased risk of cancer |
| Radium-228 | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | Increased risk of cancer |
| Radium-228 | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | Increased risk of cancer |
| Radium-228 | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | Increased risk of cancer |
| Nitrate | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Public Notice | Monitoring | N/A | N/A | Jun 26, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jun 26, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jun 26, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jun 26, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jun 26, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jun 26, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2021 | Resolved | N/A |
| Combined Radium (-226 and -228) | Health-Based | N/A | 9 | Mar 31, 2021 | Resolved | N/A |
| Gross Alpha, Excl. Radon and U | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | N/A |
| Gross Alpha, Excl. Radon and U | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | N/A |
| Gross Alpha, Excl. Radon and U | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | N/A |
| Gross Alpha, Excl. Radon and U | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | N/A |
| Combined Uranium | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | N/A |
| Combined Uranium | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | N/A |
| Nitrate | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Combined Uranium | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | N/A |
| Nitrate | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Radium-226 | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | Increased risk of cancer |
| Combined Radium (-226 and -228) | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | N/A |
| Combined Radium (-226 and -228) | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | N/A |
| Radium-226 | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | Increased risk of cancer |
| Radium-228 | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | Increased risk of cancer |
| Radium-228 | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | Increased risk of cancer |
| Radium-228 | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | Increased risk of cancer |
| Radium-226 | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | Increased risk of cancer |
| Combined Radium (-226 and -228) | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | N/A |
| Chlorine | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | Eye and nose irritation; stomach discomfort |
| Chlorine | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | Eye and nose irritation; stomach discomfort |
| Chlorine | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | Eye and nose irritation; stomach discomfort |
| Combined Radium (-226 and -228) | Health-Based | N/A | 9 | Mar 31, 2021 | Resolved | N/A |
| Chlorine | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | Eye and nose irritation; stomach discomfort |
| Chlorine | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | Eye and nose irritation; stomach discomfort |
| Combined Radium (-226 and -228) | Health-Based | N/A | 9 | Mar 31, 2021 | Resolved | N/A |
| Combined Radium (-226 and -228) | Health-Based | N/A | 9 | Mar 31, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Mar 13, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Mar 13, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Mar 13, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 28, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 28, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 28, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 28, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 28, 2021 | Resolved | N/A |
Lead & Copper Levels
Violation Timeline
2025(7)
Combined Radium (-226 and -228)
02
Combined Radium (-226 and -228)
02
Combined Radium (-226 and -228)
02
Combined Radium (-226 and -228)
02
Combined Radium (-226 and -228)
02
Combined Radium (-226 and -228)
02
Combined Radium (-226 and -228)
02
2024(58)
Combined Radium (-226 and -228)
02
Combined Radium (-226 and -228)
02
Combined Radium (-226 and -228)
02
Total Haloacetic Acids (HAA5)
27
Combined Radium (-226 and -228)
02
TTHM
27
Public Notice
75
Public Notice
75
Public Notice
75
Chlorine
27
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Chlorine
27
Chlorine
27
Chlorine
27
Chlorine
27
Nitrate
03
Nitrate
03
Nitrate
03
Nitrate
03
Nitrate
03
Combined Radium (-226 and -228)
02
Combined Radium (-226 and -228)
02
Combined Radium (-226 and -228)
02
Combined Radium (-226 and -228)
02
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Consumer Confidence Rule
71
Public Notice
75
Revised Total Coliform Rule
4B
Revised Total Coliform Rule
4B
Revised Total Coliform Rule
4B
Revised Total Coliform Rule
4B
Revised Total Coliform Rule
4B
Public Notice
75
Lead and Copper Rule
66
Lead and Copper Rule
66
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
2023(240)
Nitrate
03
Chlorine
27
Combined Radium (-226 and -228)
02
Combined Radium (-226 and -228)
02
Combined Radium (-226 and -228)
02
Combined Radium (-226 and -228)
02
Combined Radium (-226 and -228)
02
Nitrate
03
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Nitrate
03
Nitrate
03
Nitrate
03
Chlorine
27
Chlorine
27
Chlorine
27
Chlorine
27
Chlorine
27
Chlorine
27
Chlorine
27
Chlorine
27
Revised Total Coliform Rule
3A
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
E. COLI
34
E. COLI
34
E. COLI
34
E. COLI
34
Public Notice
75
E. COLI
34
E. COLI
34
E. COLI
34
E. COLI
34
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Radium-228
03
Radium-226
03
Radium-226
03
Radium-226
03
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Combined Radium (-226 and -228)
02
Combined Radium (-226 and -228)
02
Combined Radium (-226 and -228)
02
Combined Radium (-226 and -228)
02
Combined Radium (-226 and -228)
02
Chlorine
27
Radium-228
03
Combined Radium (-226 and -228)
03
Combined Radium (-226 and -228)
03
Combined Radium (-226 and -228)
03
Combined Radium (-226 and -228)
03
Combined Radium (-226 and -228)
03
Chlorine
27
Chlorine
27
Chlorine
27
Chlorine
27
Combined Uranium
03
Radium-226
03
Radium-226
03
Combined Uranium
03
Combined Uranium
03
Combined Uranium
03
Combined Uranium
03
Radium-228
03
Radium-228
03
Radium-228
03
Gross Alpha, Excl. Radon and U
03
Gross Alpha, Excl. Radon and U
03
Gross Alpha, Excl. Radon and U
03
Gross Alpha, Excl. Radon and U
03
Gross Alpha, Excl. Radon and U
03
Gross Alpha, Excl. Radon and U
03
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Public Notice
75
Public Notice
75
Public Notice
75
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Public Notice
75
Public Notice
75
Public Notice
75
Consumer Confidence Rule
71
Combined Uranium
03
Gross Alpha, Excl. Radon and U
03
Gross Alpha, Excl. Radon and U
03
Gross Alpha, Excl. Radon and U
03
Gross Alpha, Excl. Radon and U
03
Combined Uranium
03
Combined Uranium
03
Combined Uranium
03
Combined Uranium
03
Radium-226
03
Radium-226
03
Radium-226
03
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Combined Radium (-226 and -228)
02
Combined Radium (-226 and -228)
02
Combined Radium (-226 and -228)
02
Radium-226
03
Radium-226
03
Chlorine
27
Chlorine
27
Chlorine
27
Lead and Copper Rule
52
Lead and Copper Rule
52
Lead and Copper Rule
52
Lead and Copper Rule
52
Chlorine
27
Chlorine
27
Combined Radium (-226 and -228)
02
Lead and Copper Rule
52
Lead and Copper Rule
52
Combined Radium (-226 and -228)
02
Radium-228
03
Radium-228
03
Nitrate
03
Nitrate
03
Nitrate
03
Nitrate
03
Nitrate
03
Nitrate
03
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Gross Alpha, Excl. Radon and U
03
Consumer Confidence Rule
71
Consumer Confidence Rule
71
Combined Radium (-226 and -228)
03
Combined Radium (-226 and -228)
03
Combined Radium (-226 and -228)
03
Combined Radium (-226 and -228)
03
Combined Radium (-226 and -228)
03
Radium-228
03
Radium-228
03
Radium-228
03
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Radium-226
03
Radium-226
03
Revised Total Coliform Rule
3A
Nitrate
03
Nitrate
03
Gross Alpha, Excl. Radon and U
03
Gross Alpha, Excl. Radon and U
03
Gross Alpha, Excl. Radon and U
03
Radium-226
03
Gross Alpha, Excl. Radon and U
03
Gross Alpha, Excl. Radon and U
03
Gross Alpha, Excl. Radon and U
03
Combined Uranium
03
Combined Uranium
03
Combined Uranium
03
Combined Radium (-226 and -228)
02
Combined Radium (-226 and -228)
02
Combined Uranium
03
Combined Uranium
03
Chlorine
27
Chlorine
27
Radium-226
03
Combined Radium (-226 and -228)
03
Combined Radium (-226 and -228)
03
Combined Radium (-226 and -228)
03
Combined Radium (-226 and -228)
03
Combined Radium (-226 and -228)
03
Radium-228
03
Radium-228
03
Radium-228
03
Radium-228
03
Radium-228
03
Combined Radium (-226 and -228)
02
Combined Radium (-226 and -228)
02
Combined Radium (-226 and -228)
02
Nitrate
03
Nitrate
03
Chlorine
27
Chlorine
27
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Radium-226
03
Chlorine
27
Nitrate
03
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Public Notice
75
Public Notice
75
Public Notice
75
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
2022(222)
Radium-226
03
Nitrate
03
Nitrate
03
Nitrate
03
Nitrate
03
Nitrate
03
Nitrate
03
Radium-226
03
Radium-226
03
Radium-226
03
Radium-226
03
Lead and Copper Rule
52
Radium-228
03
Radium-228
03
Radium-228
03
Radium-228
03
Radium-228
03
Lead and Copper Rule
52
Lead and Copper Rule
52
Lead and Copper Rule
52
Lead and Copper Rule
52
Combined Radium (-226 and -228)
02
Gross Alpha, Excl. Radon and U
03
Gross Alpha, Excl. Radon and U
03
Gross Alpha, Excl. Radon and U
03
Gross Alpha, Excl. Radon and U
03
Gross Alpha, Excl. Radon and U
03
Combined Uranium
03
Combined Radium (-226 and -228)
03
Combined Radium (-226 and -228)
03
Combined Radium (-226 and -228)
03
Combined Radium (-226 and -228)
03
Combined Radium (-226 and -228)
03
Combined Uranium
03
Combined Uranium
03
Combined Uranium
03
Combined Uranium
03
Combined Radium (-226 and -228)
02
Combined Radium (-226 and -228)
02
Combined Radium (-226 and -228)
02
Combined Radium (-226 and -228)
02
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Public Notice
75
Public Notice
75
Combined Radium (-226 and -228)
02
Combined Radium (-226 and -228)
02
Combined Radium (-226 and -228)
02
Combined Radium (-226 and -228)
02
Combined Radium (-226 and -228)
02
Chlorine
27
Chlorine
27
Chlorine
27
Chlorine
27
Chlorine
27
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
TTHM
27
TTHM
27
TTHM
27
TTHM
27
TTHM
27
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
TTHM
27
Total Haloacetic Acids (HAA5)
27
Total Haloacetic Acids (HAA5)
27
Total Haloacetic Acids (HAA5)
27
Total Haloacetic Acids (HAA5)
27
Total Haloacetic Acids (HAA5)
27
Public Notice
75
Public Notice
75
Public Notice
75
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Lead and Copper Rule
52
Radium-228
03
Radium-228
03
Radium-228
03
Radium-228
03
Radium-228
03
Lead and Copper Rule
52
Combined Radium (-226 and -228)
01
Lead and Copper Rule
52
Lead and Copper Rule
52
Lead and Copper Rule
52
Lead and Copper Rule
52
Gross Alpha, Excl. Radon and U
03
Combined Radium (-226 and -228)
01
Combined Radium (-226 and -228)
01
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Gross Alpha, Excl. Radon and U
03
Gross Alpha, Excl. Radon and U
03
Gross Alpha, Excl. Radon and U
03
Revised Total Coliform Rule
3A
Combined Uranium
03
Combined Uranium
03
Combined Uranium
03
Chlorine
27
Chlorine
27
Gross Alpha, Excl. Radon and U
03
Nitrate
03
Nitrate
03
Nitrate
03
Nitrate
03
Nitrate
03
Gross Alpha, Excl. Radon and U
03
Chlorine
27
Chlorine
27
Combined Uranium
03
Combined Uranium
03
Nitrate
03
Combined Radium (-226 and -228)
03
Combined Radium (-226 and -228)
03
Combined Radium (-226 and -228)
03
Combined Radium (-226 and -228)
03
Combined Radium (-226 and -228)
03
Radium-226
03
Radium-226
03
Radium-226
03
Radium-226
03
Radium-226
03
Combined Radium (-226 and -228)
01
Combined Radium (-226 and -228)
01
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Radium-226
03
Nitrate
03
Combined Uranium
03
Combined Uranium
03
Combined Uranium
03
Combined Uranium
03
Revised Total Coliform Rule
3A
Nitrate
03
Radium-226
03
Combined Radium (-226 and -228)
01
Combined Radium (-226 and -228)
01
Combined Radium (-226 and -228)
01
Combined Radium (-226 and -228)
01
Radium-226
03
Radium-226
03
Radium-226
03
Combined Radium (-226 and -228)
03
Nitrate
03
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Combined Radium (-226 and -228)
03
Combined Radium (-226 and -228)
03
Combined Radium (-226 and -228)
03
Combined Radium (-226 and -228)
03
Revised Total Coliform Rule
3A
Gross Alpha, Excl. Radon and U
03
Gross Alpha, Excl. Radon and U
03
Gross Alpha, Excl. Radon and U
03
Gross Alpha, Excl. Radon and U
03
Gross Alpha, Excl. Radon and U
03
Gross Alpha, Excl. Radon and U
03
Combined Uranium
03
Revised Total Coliform Rule
3A
Combined Radium (-226 and -228)
01
Nitrate
03
Nitrate
03
Nitrate
03
Radium-228
03
Radium-228
03
Radium-228
03
Radium-228
03
Radium-228
03
Chlorine
27
Chlorine
27
Chlorine
27
Chlorine
27
Chlorine
27
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Public Notice
75
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
2021(227)
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Combined Uranium
03
Combined Uranium
03
Combined Uranium
03
Combined Uranium
03
Combined Uranium
03
Revised Total Coliform Rule
3A
Combined Radium (-226 and -228)
01
Combined Radium (-226 and -228)
01
Gross Alpha, Excl. Radon and U
03
Gross Alpha, Excl. Radon and U
03
Gross Alpha, Excl. Radon and U
03
Gross Alpha, Excl. Radon and U
03
Gross Alpha, Excl. Radon and U
03
Combined Radium (-226 and -228)
03
Combined Radium (-226 and -228)
03
Combined Radium (-226 and -228)
03
Combined Radium (-226 and -228)
03
Combined Radium (-226 and -228)
03
Radium-226
03
Radium-226
03
Radium-226
03
Radium-226
03
Radium-226
03
Lead and Copper Rule
52
Revised Total Coliform Rule
3A
Lead and Copper Rule
52
Lead and Copper Rule
52
Lead and Copper Rule
52
Lead and Copper Rule
52
Combined Radium (-226 and -228)
01
Nitrate
03
Radium-228
03
Radium-228
03
Nitrate
03
Nitrate
03
Nitrate
03
Chlorine
27
Chlorine
27
Chlorine
27
Radium-228
03
Radium-228
03
Radium-228
03
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Nitrate
03
Nitrate
03
Combined Radium (-226 and -228)
01
Gross Alpha, Excl. Radon and U
03
Chlorine
27
Chlorine
27
Radium-228
03
Radium-228
03
Radium-228
03
Combined Uranium
03
Combined Uranium
03
Combined Uranium
03
Combined Uranium
03
Combined Uranium
03
Nitrate
03
Nitrate
03
Nitrate
03
Combined Radium (-226 and -228)
03
Combined Radium (-226 and -228)
03
Combined Radium (-226 and -228)
03
Combined Radium (-226 and -228)
03
Gross Alpha, Excl. Radon and U
03
Radium-228
03
Radium-228
03
Radium-226
03
Radium-226
03
Combined Radium (-226 and -228)
03
Radium-226
03
Radium-226
03
Radium-226
03
Gross Alpha, Excl. Radon and U
03
Gross Alpha, Excl. Radon and U
03
Nitrate
03
Nitrate
03
Gross Alpha, Excl. Radon and U
03
Gross Alpha, Excl. Radon and U
03
Combined Radium (-226 and -228)
01
Combined Radium (-226 and -228)
01
Combined Radium (-226 and -228)
01
Combined Radium (-226 and -228)
01
Combined Radium (-226 and -228)
01
Combined Radium (-226 and -228)
01
Combined Radium (-226 and -228)
01
Gross Alpha, Excl. Radon and U
03
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
TTHM
27
TTHM
27
TTHM
27
TTHM
27
TTHM
27
TTHM
27
Total Haloacetic Acids (HAA5)
27
Total Haloacetic Acids (HAA5)
27
Total Haloacetic Acids (HAA5)
27
Total Haloacetic Acids (HAA5)
27
Total Haloacetic Acids (HAA5)
27
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Nitrate
03
Nitrate
03
Radium-226
03
Radium-226
03
Radium-226
03
Radium-226
03
Lead and Copper Rule
52
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Combined Radium (-226 and -228)
01
Combined Radium (-226 and -228)
01
Combined Radium (-226 and -228)
01
Combined Radium (-226 and -228)
01
Nitrate
03
Revised Total Coliform Rule
3A
Lead and Copper Rule
52
Lead and Copper Rule
52
Gross Alpha, Excl. Radon and U
03
Gross Alpha, Excl. Radon and U
03
Gross Alpha, Excl. Radon and U
03
Gross Alpha, Excl. Radon and U
03
Combined Uranium
03
Combined Uranium
03
Combined Uranium
03
Combined Uranium
03
Consumer Confidence Rule
71
Consumer Confidence Rule
71
Consumer Confidence Rule
71
Revised Total Coliform Rule
3A
Combined Radium (-226 and -228)
03
Combined Radium (-226 and -228)
03
Combined Radium (-226 and -228)
03
Combined Radium (-226 and -228)
03
Lead and Copper Rule
52
Lead and Copper Rule
52
Chlorine
27
Chlorine
27
Chlorine
27
Chlorine
27
Chlorine
27
Radium-228
03
Radium-228
03
Radium-228
03
Radium-228
03
Nitrate
03
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Combined Radium (-226 and -228)
01
Gross Alpha, Excl. Radon and U
03
Gross Alpha, Excl. Radon and U
03
Gross Alpha, Excl. Radon and U
03
Gross Alpha, Excl. Radon and U
03
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Combined Uranium
03
Combined Uranium
03
Nitrate
03
Nitrate
03
Nitrate
03
Combined Uranium
03
Nitrate
03
Nitrate
03
Radium-226
03
Combined Radium (-226 and -228)
03
Combined Radium (-226 and -228)
03
Radium-226
03
Radium-228
03
Radium-228
03
Radium-228
03
Radium-226
03
Combined Radium (-226 and -228)
03
Chlorine
27
Chlorine
27
Chlorine
27
Combined Radium (-226 and -228)
01
Chlorine
27
Chlorine
27
Combined Radium (-226 and -228)
01
Combined Radium (-226 and -228)
01
Public Notice
75
Public Notice
75
Public Notice
75
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
How Does This Compare?
ABERDEEN (28315) has 754 recorded violations, including 74 health-based. 17 remain unresolved. Consider testing your tap water independently for added peace of mind.
Recommended Water Filters
Based on the contaminants detected in your area, these filter types may help improve your water quality.
Reverse Osmosis System
Highly effective at removing heavy metals, dissolved solids, and a wide range of contaminants. Recommended for homes with lead or arsenic concerns.
Targets:Lead, Copper, Arsenic, Mercury, Cadmium
Look for:NSF/ANSI 58 certified
Activated Carbon Filter
Excellent for removing chlorine, chloramine, and disinfection byproducts like THMs and HAAs. Available as pitcher filters, countertop, or under-sink units.
Targets:THMs, HAAs, Chlorine, Chloramine, Taste & Odor
Look for:NSF/ANSI 42 & 53 certified
UV Water Purifier
Uses ultraviolet light to neutralize bacteria, viruses, and parasites without chemicals. Ideal for homes with microbial contamination concerns.
Targets:E. coli, Coliform, Giardia, Cryptosporidium
Look for:NSF/ANSI 55 (Class A) certified
Always look for filters certified by NSF International for the specific contaminants you want to remove.